StockMacro
Company, fund or insider

Help

Menu

DNA X

$1.51 -65% in 6 monthsMarket cap $2.2M

SONM on XNAS, Technology, DNA X, Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 79% in a year while the company lost $8.5M and filed a late-filing notice.

  • BadCash of just $900K on the balance sheet
  • WatchTwo director or officer changes filed in the last 90 days

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Jun 2026

DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.

Industry
Telephone & telegraph apparatus (Technology)
Employees
4
Website
dnax.us
Listed
Nasdaq, US
Last results
20 May 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Jun 2026: net loss $1.2M.
Quarter to 31 Dec 2021: revenue $15.9M, net income -$11.7MQuarter to 31 Dec 2021: revenue $15.9M, net income -$11.7MQuarter to 31 Mar 2022: revenue $13.3M, net income -$7.2MQuarter to 31 Mar 2022: revenue $13.3M, net income -$7.2MQuarter to 30 Jun 2022: revenue $12.0M, net income -$4.2MQuarter to 30 Jun 2022: revenue $12.0M, net income -$4.2MQuarter to 30 Sep 2022: revenue $20.5M, net income -$1.6MQuarter to 30 Sep 2022: revenue $20.5M, net income -$1.6MQuarter to 31 Dec 2022: revenue $24.1M, net income -$1.0MQuarter to 31 Dec 2022: revenue $24.1M, net income -$1.0MQuarter to 31 Mar 2023: revenue $25.8M, net income $227KQuarter to 31 Mar 2023: revenue $25.8M, net income $227KQuarter to 30 Jun 2023: revenue $26.8M, net income $509KQuarter to 30 Jun 2023: revenue $26.8M, net income $509KQuarter to 30 Sep 2023: revenue $27.6M, net income $527KQuarter to 30 Sep 2023: revenue $27.6M, net income $527KQuarter to 31 Dec 2023: revenue $13.4M, net income -$1.4MQuarter to 31 Dec 2023: revenue $13.4M, net income -$1.4MQuarter to 31 Mar 2024: revenue $16.8M, net income -$2.9MQuarter to 31 Mar 2024: revenue $16.8M, net income -$2.9MQuarter to 30 Jun 2024: revenue $11.5M, net income -$6.6MQuarter to 30 Jun 2024: revenue $11.5M, net income -$6.6MQuarter to 30 Sep 2024: revenue $15.0M, net income -$2.5MQuarter to 30 Sep 2024: revenue $15.0M, net income -$2.5MQuarter to 31 Dec 2024: revenue $15.0M, net income -$21.6MQuarter to 31 Dec 2024: revenue $15.0M, net income -$21.6MQuarter to 31 Mar 2025: revenue $16.7M, net income $458KQuarter to 31 Mar 2025: revenue $16.7M, net income $458KQuarter to 30 Jun 2025: revenue $11.2M, net income -$7.5MQuarter to 30 Jun 2025: revenue $11.2M, net income -$7.5MQuarter to 30 Sep 2025: revenue $16.2M, net income -$4.8MQuarter to 30 Sep 2025: revenue $16.2M, net income -$4.8MQuarter to 31 Dec 2025: revenue –, net income -$8.9MQuarter to 31 Mar 2026: revenue –, net income $6.3MQuarter to 30 Jun 2026: revenue –, net income -$1.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $27.6M30 Jun 2026
See the numbers
Quarter toRevenueNet income
30 Jun 2026–-$1.2M
31 Mar 2026–$6.3M
31 Dec 2025–-$8.9M
30 Sep 2025$16.2M-$4.8M
30 Jun 2025$11.2M-$7.5M
31 Mar 2025$16.7M$458K
31 Dec 2024$15.0M-$21.6M
30 Sep 2024$15.0M-$2.5M
30 Jun 2024$11.5M-$6.6M
31 Mar 2024$16.8M-$2.9M
31 Dec 2023$13.4M-$1.4M
30 Sep 2023$27.6M$527K
30 Jun 2023$26.8M$509K
31 Mar 2023$25.8M$227K
31 Dec 2022$24.1M-$1.0M
30 Sep 2022$20.5M-$1.6M
30 Jun 2022$12.0M-$4.2M
31 Mar 2022$13.3M-$7.2M
31 Dec 2021$15.9M-$11.7M
Fundamentals, 12 months to 30 Jun 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – $57.9M
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +21%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$8.5M -$31.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – 22.9% 35.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – -46.3% 5.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – -53.8% 5.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – 10.9%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $900K $2.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $2.9M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – $910K
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.37
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 29.4
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 1.8
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 3.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.3

Latest = 12 months to 30 Jun 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
DNA XSONM (this company) $2.2Mloss–––
ClearOneCLRO $11.6Mloss–––
Franklin WirelessFKWL $17.1Mloss0.65-42%-23.2%
FiEEFIEE $23.2M3.91.7+594%43.0%
authIDAUID $2.3Mloss1.4––
Iveda SolutionsIVDA $2.1Mloss0.50-29%-83.5%

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

6.3%

93K shares held by 13F filers (30 Sep 2026) of 1.5M outstanding (18 Aug 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0.7%

9,830 shares sold short (30 Oct 2026) of 1.5M outstanding (18 Aug 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.0

9,830 shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-9.1%

11K shares sold short in the report before, 9,830 on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

18%

18% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

9

9 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

9 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $1.51 on 20 Nov 2026, -79% over 12 months (12-month range $1.51 to $7.38)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: -$1.4M).
Revenue per quarter. Revenue $16.2M in the latest quarter, +7.9% on a year earlier.
Capital spending per quarter. Capital spending $8K in the latest quarter, -33% on a year earlier.
Institutional holders (13F filers). 9 13F filers reported holding it in the latest 13F quarter, -36% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 20268-K and other filingsReport will be filed late
16 Nov 20268-K and other filingsActing CEO and Executive Chairman Mike Mulica granted a substitute cash award in lieu of RSUs, based on $50,000 of phantom RSUs
27 Aug 20268-K and other filingsDirector or officer change
27 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Aug 20268-K and other filingsReport will be filed late
4 Jun 20268-K and other filingsA major agreement ended
27 May 20268-K and other filingsDelisting notice or listing transfer
15 May 20268-K and other filingsReport will be filed late
30 Apr 20268-K and other filingsChanged its auditor
1 Apr 20268-K and other filingsReport will be filed late
10 Feb 20268-K and other filingsDirector or officer change
5 Feb 20268-K and other filingsDirector or officer change
27 Jan 20268-K and other filingsCompleted an acquisition or asset sale
27 Jan 20268-K and other filingsA major agreement ended
18 Dec 20258-K and other filingsCompleted an acquisition or asset sale
5 Dec 20258-K and other filingsDirector or officer change
28 Oct 2025Sharp changeShort interest spike: short interest spike, 736K vs usual 68K (2025-10-15); 10.8x the same period a year earlier
20 Oct 20258-K and other filingsDirector or officer change
20 Oct 20258-K and other filingsDelisting notice or listing transfer
14 Oct 2025Sharp changeShort interest spike: short interest spike, 1.1M vs usual 68K (2025-09-30); 15.7x the same period a year earlier
9 Oct 20258-K and other filingsRegistered new securities for sale (S-1)
29 Sep 20258-K and other filingsRegistered new securities for sale (S-1)
27 Aug 20258-K and other filingsDelisting notice or listing transfer
14 Aug 20258-K and other filingsDelisting notice or listing transfer
12 Aug 20258-K and other filingsDirector or officer change
23 Jul 20258-K and other filingsDirector or officer change
23 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
5 Jun 20258-K and other filingsChanged its auditor
21 Apr 20258-K and other filingsDirector or officer change
16 Apr 20258-K and other filingsDirector or officer change
3 Apr 20258-K and other filingsDirector or officer change
11 Feb 20258-K and other filingsDirector or officer change
11 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 510K vs usual 139K (2024-07-15); 2.0x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 629K vs usual 139K (2024-06-28); 2.4x the same period a year earlier
21 Jun 20248-K and other filingsDirector or officer change
21 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Mar 20248-K and other filingsDelisting notice or listing transfer
11 Dec 20238-K and other filingsDirector or officer change
28 Nov 20238-K and other filingsDirector or officer change
28 Sep 20238-K and other filingsDirector or officer change
18 Sep 20238-K and other filingsDelisting notice or listing transfer
9 Aug 20238-K and other filingsDirector or officer change
9 Aug 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 25.8M vs usual 13.9M (2023-03-31); 1.9x the same period a year earlier
21 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 24.1M vs usual 13.9M (2022-12-31); 1.5x the same period a year earlier
21 Feb 20238-K and other filingsDelisting notice or listing transfer
27 Oct 20228-K and other filingsDirector or officer change
23 Aug 20228-K and other filingsDirector or officer change
22 Aug 20228-K and other filingsDelisting notice or listing transfer
11 Aug 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 4 filing(s) in 30 days, value_usd total 21.8M)
28 Jul 20228-K and other filingsPrivate placement of securities (Form D)
20 Jul 20228-K and other filingsDirector or officer change
13 Jul 20228-K and other filingsDirector or officer change
13 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Apr 20228-K and other filingsDirector or officer change
18 Feb 20228-K and other filingsDelisting notice or listing transfer
7 Feb 20228-K and other filingsDirector or officer change
7 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jun 2022: -$8K published
Month from 1 Jul 2022: $12.5M published
Month from 1 Aug 2022: $9.3M published
Month from 1 Mar 2023: $1K published
Month from 1 Sep 2023: $59K published
Month from 1 Jun 2024: -$99K published
Month from 1 Jul 2024: -$18K published
Month from 1 Nov 2024: -$8K published
Month from 1 Apr 2025: -$177K published
Month from 1 Jul 2025: -$1.3M published
Revenue per quarter
Quarter ended 31 Dec 2021: $15.9M, +0.6% on a year earlier; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $13.3M, +8.3% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $12.0M, 0% on a year earlier; public on 13 Aug 2022
Quarter ended 30 Sep 2022: $20.5M, +42% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $24.1M, +51% on a year earlier; public on 21 Mar 2023
Quarter ended 31 Mar 2023: $25.8M, +95% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $26.8M, +124% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $27.6M, +34% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $13.4M, -44% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $16.8M, -35% on a year earlier; public on 15 May 2024
Quarter ended 30 Jun 2024: $11.5M, -57% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $15.0M, -46% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $15.0M, +12% on a year earlier; public on 1 Apr 2025
Quarter ended 31 Mar 2025: $16.7M, -0.3% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $11.2M, -2.8% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $16.2M, +7.9% on a year earlier; public on 1 Nov 2025
Capital spending per quarter
Quarter ended 31 Dec 2021: $26K; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $3K; public on 11 May 2022
Quarter ended 30 Jun 2022: $3K; public on 13 Aug 2022
Quarter ended 31 Dec 2022: $2K, -92% on a year earlier; public on 21 Mar 2023
Quarter ended 30 Sep 2023: $1K; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $12K, +500% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $30K; public on 15 May 2024
Quarter ended 30 Jun 2024: $39K; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $137K, +13600% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $8K, -33% on a year earlier; public on 1 Apr 2025
Institutional holders (13F filers)
31 Dec 2021 report: 15; public on 14 Feb 2022
31 Mar 2022 report: 13; public on 16 May 2022
30 Jun 2022 report: 12; public on 15 Aug 2022
30 Sep 2022 report: 17; public on 14 Nov 2022
31 Dec 2022 report: 13; public on 14 Feb 2023
31 Mar 2023 report: 13; public on 15 May 2023
30 Jun 2023 report: 12; public on 14 Aug 2023
30 Sep 2023 report: 16; public on 14 Nov 2023
31 Dec 2023 report: 18; public on 14 Feb 2024
31 Mar 2024 report: 20; public on 15 May 2024
30 Jun 2024 report: 17; public on 14 Aug 2024
30 Sep 2024 report: 9; public on 14 Nov 2024
31 Dec 2024 report: 10; public on 14 Feb 2025
31 Mar 2025 report: 11; public on 15 May 2025
30 Jun 2025 report: 16; public on 14 Aug 2025
30 Sep 2025 report: 14; public on 14 Nov 2025
31 Dec 2025 report: 8; public on 17 Feb 2026
31 Mar 2026 report: 9; public on 15 May 2026
30 Jun 2026 report: 9; public on 14 Aug 2026
30 Sep 2026 report: 9; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $1.3M (30 Jun 2025), 310× its normal reading; higher than 96% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: -$1.4M).
  • Revenue per quarter: Revenue $16.2M in the latest quarter, +7.9% on a year earlier.
  • Capital spending per quarter: Capital spending $8K in the latest quarter, -33% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 42 insider trades

No trades in the last 90 days; the latest was filed 30 Jun 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
30 Jun 2025Laurence W Lytton10% ownerSell866,916$1.45$1.3MForm 4
25 Apr 2025Clayton CroliusChief Financial OfficerSell11,634$1.45$17KForm 4
25 Apr 2025Jack SteenstraDirectorSell23,381$1.45$34KForm 4
25 Apr 2025Charles BecherSee RemarksSell31,326$1.45$45KForm 4
25 Apr 2025Jeffrey WangDirectorSell4,478$1.45$6KForm 4
25 Apr 2025Michael C MulicaDirectorSell27,818$1.45$40KForm 4
25 Apr 2025James S CassanoDirectorSell23,381$1.45$34KForm 4
14 Nov 2024Michael C MulicaDirectorSell2,559$3.28$8KForm 4

9 institutions reported shares at the end of Q3 2026, 6% of the shares outstanding; 1 opened a position, 1 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
C2C Wealth Management, LLC48K3.19%$217K+12K+34%
Citadel Advisors LLC18K1.19%$81K+5,037+40%
BlackRock, Inc.14K0.94%$64KNo change
Vanguard Capital Management LLC5,9010.40%$27KNo change
Vanguard Fiduciary Trust Co4,4960.30%$21KNo change
UBS Group AG3,1280.21%$14K+824+36%
Robinhood Markets, Inc.2200.01%$1K
SBI Securities Co., Ltd.2170.01%$991+3+1.4%
Tower Research Capital LLC (TRC)810.01%$370-561-87%
JPMorgan Chase & Co410.00%$172New+41

Company events

All 90 company events

In 12 months: 5 major agreements, 5 director or officer changes, 4 late reports, 2 completed deals. Results releases and routine reports are left out.

FiledWhat happenedSource
17 Nov 2026Quarterly report will be filed lateNT 10-Q
16 Nov 2026Acting CEO and Executive Chairman Mike Mulica granted a substitute cash award in lieu of RSUs, based on $50,000 of phantom RSUs8-K
27 Aug 2026Director or officer change8-K
14 Aug 2026Quarterly report will be filed lateNT 10-Q
2 Jul 2026Signed a major agreementSame filing: sold shares privately, changed shareholder rights, changed its bylaws or fiscal year8-K
4 Jun 2026A major agreement ended8-K
27 May 2026Signed a major agreement; Delisting notice or listing transferSame filing: took on new debt, sold shares privately8-K
15 May 2026Quarterly report will be filed lateNT 10-Q

The 5 newest of 23 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

30 Jun 2020confirmed

Confirmed across sources Insiders and Short interest and volume

DNA X (SONM): had 4 insiders buy $246K of its shares on the open market within 30 days (4 filings), while it had 671K shares sold short in the 15 Jun 2020 report, 4.0× the same report last year. Two unrelated kinds of activity within 18 days.

  • Insiders: Clustered insider buying, became public on 12 Jun 2020
  • Short interest and volume: Short interest spike, became public on 25 Jun 2020
2019-06-14: 166K2019-06-28: 40K2019-07-15: 115K2019-07-31: 119K2019-08-15: 108K2019-08-30: 131K2019-09-13: 112K2019-09-30: 329K2019-10-15: 373K2019-10-31: 242K2019-11-15: 240K2019-11-29: 205K2019-12-13: 247K2019-12-31: 372K2020-01-15: 330K2020-01-31: 272K2020-02-14: 305K2020-02-28: 312K2020-03-13: 293K2020-03-31: 225K2020-04-15: 202K2020-04-30: 303K2020-05-15: 419K2020-05-29: 494K2020-06-15: 671K
The 15 Jun 2020 report against the 24 reports before it. this reportearliernormal: 244K
See the evidence (2 changes)

Insiders: Clustered insider buying became public on 12 Jun 2020

DNA X had 4 insiders buy $246K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$246K
Window
13 May 2020 to 12 Jun 2020
  • Hochschild Maurice (director) bought 15,000 shares of SONM ($11,250)dated 11 Jun 2020, public 12 Jun 2020
  • Howe Alan B (director) bought 13,333 shares of SONM ($10,000)dated 11 Jun 2020, public 12 Jun 2020
  • TIRVA ROBERT L. (Chief Financial Officer) bought 100,000 shares of SONM ($75,000)dated 11 Jun 2020, public 12 Jun 2020
  • Wilkinson Thomas Wiley (Chief Executive Officer) bought 200,000 shares of SONM ($150,000)dated 11 Jun 2020, public 12 Jun 2020

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 25 Jun 2020

DNA X had 671K shares sold short in the 15 Jun 2020 report, 4.0× the same report last year.

This period
671K (the 15 Jun 2020 report)
Normal report (median of 24 earlier)
244K
Typical spread (median absolute deviation)
81K
How far from its usual level
+3.5
Same report last year
166K
History used
397 days
2019-06-14: 166K2019-06-28: 40K2019-07-15: 115K2019-07-31: 119K2019-08-15: 108K2019-08-30: 131K2019-09-13: 112K2019-09-30: 329K2019-10-15: 373K2019-10-31: 242K2019-11-15: 240K2019-11-29: 205K2019-12-13: 247K2019-12-31: 372K2020-01-15: 330K2020-01-31: 272K2020-02-14: 305K2020-02-28: 312K2020-03-13: 293K2020-03-31: 225K2020-04-15: 202K2020-04-30: 303K2020-05-15: 419K2020-05-29: 494K2020-06-15: 671K
the 15 Jun 2020 report24 earlier reportsnormal: 244K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 17 Nov 2026Filings record

    Report will be filed late

  2. 16 Nov 2026Filings record

    Acting CEO and Executive Chairman Mike Mulica granted a substitute cash award in lieu of RSUs, based on $50,000 of phantom RSUs

  3. 27 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 27 Aug 2026Filings record

    Director or officer change

  5. 14 Aug 2026Filings record

    Report will be filed late

  6. 4 Jun 2026Filings record

    A major agreement ended

  7. 27 May 2026Filings record

    Delisting notice or listing transfer

  8. 15 May 2026Filings record

    Report will be filed late

  9. 30 Apr 2026Filings record

    Changed its auditor

  10. 1 Apr 2026Filings record

    Report will be filed late

  11. 10 Feb 2026Filings record

    Director or officer change

  12. 5 Feb 2026Filings record

    Director or officer change

  13. 27 Jan 2026Filings record

    Completed an acquisition or asset sale

  14. 27 Jan 2026Filings record

    A major agreement ended

  15. 18 Dec 2025Filings record

    Completed an acquisition or asset sale

  16. 5 Dec 2025Filings record

    Director or officer change

  17. 25 Oct 2025Short interest and volume change

    had 736K shares sold short in the 15 Oct 2025 report, 11× the same report last year.

    Same report last year: 68K; its normal report is 68K.

    See the evidence
    This period
    736K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    68K
    Typical spread (median absolute deviation)
    30K
    How far from its usual level
    +13.4
    Same report last year
    68K
    History used
    2,345 days
    2024-10-15: 68K2024-10-31: 42K2024-11-15: 39K2024-11-29: 23K2024-12-13: 38K2024-12-31: 49K2025-01-15: 65K2025-01-31: 115K2025-02-14: 69K2025-02-28: 59K2025-03-14: 62K2025-03-31: 82K2025-04-15: 128K2025-04-30: 11K2025-05-15: 21K2025-05-30: 212K2025-06-13: 241K2025-06-30: 1.6M2025-07-15: 101K2025-07-31: 157K2025-08-15: 65K2025-08-29: 85K2025-09-15: 92K2025-09-30: 1.1M2025-10-15: 736K
    the 15 Oct 2025 report24 earlier reportsnormal: 68K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 20 Oct 2025Filings record

    Director or officer change

  19. 20 Oct 2025Filings record

    Delisting notice or listing transfer

  20. 10 Oct 2025Short interest and volume change

    had 1.1M shares sold short in the 30 Sep 2025 report, 16× the same report last year.

    Same report last year: 72K; its normal report is 68K.

    See the evidence
    This period
    1.1M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    68K
    Typical spread (median absolute deviation)
    28K
    How far from its usual level
    +21.2
    Same report last year
    72K
    History used
    2,330 days
    2024-09-30: 72K2024-10-15: 68K2024-10-31: 42K2024-11-15: 39K2024-11-29: 23K2024-12-13: 38K2024-12-31: 49K2025-01-15: 65K2025-01-31: 115K2025-02-14: 69K2025-02-28: 59K2025-03-14: 62K2025-03-31: 82K2025-04-15: 128K2025-04-30: 11K2025-05-15: 21K2025-05-30: 212K2025-06-13: 241K2025-06-30: 1.6M2025-07-15: 101K2025-07-31: 157K2025-08-15: 65K2025-08-29: 85K2025-09-15: 92K2025-09-30: 1.1M
    the 30 Sep 2025 report24 earlier reportsnormal: 68K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 9 Oct 2025Filings record

    Registered new securities for sale (S-1)

  22. 29 Sep 2025Filings record

    Registered new securities for sale (S-1)

  23. 27 Aug 2025Filings record

    Delisting notice or listing transfer

  24. 14 Aug 2025Filings record

    Delisting notice or listing transfer

  25. 12 Aug 2025Filings record

    Director or officer change

  26. 23 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 23 Jul 2025Filings record

    Director or officer change

  28. 20 Jun 2025Filings record

    Registered new securities for sale (S-1)

  29. 5 Jun 2025Filings record

    Changed its auditor

  30. 21 Apr 2025Filings record

    Director or officer change

  31. 16 Apr 2025Filings record

    Director or officer change

  32. 3 Apr 2025Filings record

    Director or officer change

  33. 11 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 11 Feb 2025Filings record

    Director or officer change

  35. 25 Jul 2024Short interest and volume change

    had 510K shares sold short in the 15 Jul 2024 report, 2.0× the same report last year.

    Same report last year: 261K; its normal report is 139K.

    See the evidence
    This period
    510K (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    139K
    Typical spread (median absolute deviation)
    67K
    How far from its usual level
    +3.8
    Same report last year
    261K
    History used
    1,888 days
    2023-07-14: 261K2023-07-31: 137K2023-08-15: 133K2023-08-31: 490K2023-09-15: 305K2023-09-29: 311K2023-10-13: 298K2023-10-31: 184K2023-11-15: 247K2023-11-30: 186K2023-12-15: 142K2023-12-29: 64K2024-01-12: 73K2024-01-31: 45K2024-02-15: 72K2024-02-29: 122K2024-03-15: 119K2024-03-28: 118K2024-04-15: 90K2024-04-30: 73K2024-05-15: 99K2024-05-31: 262K2024-06-14: 404K2024-06-28: 629K2024-07-15: 510K
    the 15 Jul 2024 report24 earlier reportsnormal: 139K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 11 Jul 2024Short interest and volume change

    had 629K shares sold short in the 28 Jun 2024 report, 2.4× the same report last year.

    Same report last year: 258K; its normal report is 139K.

    See the evidence
    This period
    629K (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    139K
    Typical spread (median absolute deviation)
    67K
    How far from its usual level
    +5.0
    Same report last year
    258K
    History used
    1,871 days
    2023-06-30: 258K2023-07-14: 261K2023-07-31: 137K2023-08-15: 133K2023-08-31: 490K2023-09-15: 305K2023-09-29: 311K2023-10-13: 298K2023-10-31: 184K2023-11-15: 247K2023-11-30: 186K2023-12-15: 142K2023-12-29: 64K2024-01-12: 73K2024-01-31: 45K2024-02-15: 72K2024-02-29: 122K2024-03-15: 119K2024-03-28: 118K2024-04-15: 90K2024-04-30: 73K2024-05-15: 99K2024-05-31: 262K2024-06-14: 404K2024-06-28: 629K
    the 28 Jun 2024 report24 earlier reportsnormal: 139K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 21 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 21 Jun 2024Filings record

    Director or officer change

  39. 14 Mar 2024Filings record

    Delisting notice or listing transfer

  40. 11 Dec 2023Filings record

    Director or officer change

Showing the newest 40 of 106 entries; narrow the window or the kind of data to see older ones.

Not listed: 131 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001178697
Ticker
SONM
Domain
dnax.us
Hq location
CA|SAN DIEGO|92121 (1 unverified)
Name
DNA X, Inc., Sonim Communications (India) Private Limited, Sonim Technologies Germany GmbH, Sonim Technologies (Hong Kong) Limited and 5 more
Wikidata
Q1225892
  • SEC Form 13F institutional holdings270 data points30 Jun 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)170 records7 Oct 2016 to 17 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)580 data points31 Dec 2017 to 18 Aug 2026
  • SEC Form 4 insider transactions42 records, 108 data points23 May 2019 to 30 Jun 2025
  • FINRA short interest (twice monthly)536 data points15 May 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3790 data points10 May 2019 to 20 Nov 2026